Abstract
Janet Song, Jeffrey Bien, Elena Hristova, Chrisy Mafnas
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Gastric neuroendocrine neoplasms
10.1038/s41572-024-00508-y · 2024
Unresolved referenced work
Kept as external metadata until matched
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3
10.1111/jne.13306 · 2023
10.1097/00000478-199610000-00001
10.1097/00000478-199610000-00001
10.1016/j.cgh.2023.01.037
10.1016/j.cgh.2023.01.037
Proton pump inhibitor use, hypergastrinemia, and gastric carcinoids—what is the relationship?
10.3390/ijms21020662 · 2020
Metastatic multiple gastric neuroendocrine tumors with a long history of proton pump inhibitor use: A case report
10.28982/josam.1038661 · 2022
10.3109/00365521.2011.627444
10.3109/00365521.2011.627444
10.1080/00365521.2018.1450442
10.1080/00365521.2018.1450442
10.1517/14740338.2016.1118050
10.1517/14740338.2016.1118050
Classification of gastric neuroendocrine tumors and associations with survival
10.1002/jso.27876 · 2025
10.1056/nejmra021405
10.1056/nejmra021405
Diagnostic value of circulating chromogranin A for neuroendocrine tumors: a systematic review and meta-analysis
10.1371/journal.pone.0124884 · 2015
The association between proton pump inhibitor use and gastroenteropancreatic neuroendocrine tumors: a systematic review
10.1007/s12029-025-01328-3 · 2025
All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: a thorough update
10.1111/jne.13267 · 2023
10.1056/nejm199011013231805
10.1056/nejm199011013231805
Endoscopic diagnosis and management of type I neuroendocrine tumors
10.4253/wjge.v7.i4.346 · 2015
Management of gastric neuroendocrine tumors: a review
10.1245/s10434-023-14712-9 · 2024
Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors
10.3748/wjg.v20.i1.118 · 2014
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis
10.1111/his.14220 · 2020
Association between long-term proton pump inhibitor use and low-risk gastric neuroendocrine tumors
10.1245/s10434-025-18430-2 · 2026
No additional external references are available.